Certainly, given the established role of adenosine signaling in modulating BBB permeability through the activation of adenosine receptors (A1R/A2AR) [13,14,15,16], the administration of NECA could potentially enhance the brain penetration of BUM, which could consequently improve the management of convulsions. This evidence concerns the gene ADORA2A and convulsion.